Apr 18, 2023 / 11:30AM GMT
Operator
Good afternoon, and welcome to the Diaceutics plc Investor Presentation. (Operator Instructions) Before we begin, I'd like to submit the following poll. And I'd now like to hand over to Peter Keeling, CEO. Good afternoon, sir.
Peter Keeling - Diaceutics PLC - Founder, CEO & Executive Director
Good afternoon, indeed, and good morning and good evening for those joining at different time zones. Nick and I are delighted to have the opportunity to present our 2022 results and discuss some significant progress that we've been making in the business over the last year and indeed talk a little bit about the outlook going forward.
I think one way to just book end 2022 for us. There was a lot of moving parts. But I think for 2022, overall, we made particularly strong financial progress. Nick will go into some detail on exactly what that looks like. And we were delighted to end the year ahead of initial market expectations.
And for those of you who have followed us know that a big part of our, both innovation and our corporate engineering, is to
Full Year 2022 Diaceutics PLC Earnings Call Transcript
Mar 02, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers